Biotech Values

[WorstLuck]

On June 29, 2017, the Company traded 389,600 shares of its common stock primarily to one investor under the 2016 ATM agreement at a price of $25.56 per share resulting in net proceeds of $9.6 million, after commissions and offering expenses. The cash proceeds were received on July 5, 2017, at which time the transaction settled and common stock was considered issued and outstanding.

Nice price.